Positive Outcomes of High Hemoglobin Target in Patients With Chronic Kidney Disease Not on Dialysis: A Randomized Controlled Study
Authors:
Open Access
- 25 May 2011
- journal article
- research article
- Published by Wiley in Therapeutic Apheresis and Dialysis
- Vol. 15 (5) , 431-440
Abstract
Correcting anemia in patients with chronic kidney disease (CKD) to higher hemoglobin (Hb) levels may be associated with increased risk. No optimal target for Hb has been established. This controlled study examined 321 patients with CKD who were not on dialysis, had a Hb level of P = 0.025). The left ventricular mass index (LVMI) remained stable in the low Hb group, but there was a significant decrease in LVMI in the high group (P < 0.001). There were no safety concerns with targeting a higher Hb level during the 48 weeks of this study. Patients with a higher Hb target had comparatively better outcomes with respect to quality of life and LVMI.Keywords
This publication has 23 references indexed in Scilit:
- Maintaining high hemoglobin levels improved the left ventricular mass index and quality of life scores in pre-dialysis Japanese chronic kidney disease patientsClinical and Experimental Nephrology, 2009
- Secondary analysis of the CHOIR trial epoetin-α dose and achieved hemoglobin outcomesKidney International, 2008
- Greater Epoetin alfa Responsiveness Is Associated With Improved Survival in Hemodialysis PatientsClinical Journal of the American Society of Nephrology, 2008
- C.E.R.A. Corrects Anemia in Patients with Chronic Kidney Disease not on DialysisClinical Journal of the American Society of Nephrology, 2008
- Baseline characteristics and anemia treatment for new hemodialysis patientsNihon Toseki Igakkai Zasshi, 2008
- Correction of Anemia with Erythropoietin in Chronic Kidney Disease (stage 3 or 4): Effects on Cardiac PerformanceCardiovascular Drugs and Therapy, 2007
- Correction of Anemia with Epoetin Alfa in Chronic Kidney DiseaseNew England Journal of Medicine, 2006
- Treating anemia early in renal failure patients slows the decline of renal function: A randomized controlled trialKidney International, 2004
- Reversal of Anemia by Erythropoietin Therapy Retards the Progression of Chronic Renal Failure, Especially in Nondiabetic PatientsNephron, 1997
- Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findingsThe American Journal of Cardiology, 1986